Aurora Cannabis to Host Q4/FY25 Investor Call

Ticker: ACB · Form: 6-K · Filed: 2025-06-04T00:00:00.000Z

Sentiment: neutral

Topics: earnings-call, financial-results, filing-announcement

Related Tickers: ACB

TL;DR

Aurora Cannabis (ACB) hosting Q4/FY25 earnings call June 3rd - expect financial results soon.

AI Summary

Aurora Cannabis Inc. announced on June 3, 2025, that it will host an investor conference call to discuss its fourth quarter and fiscal year 2025 results. The company, headquartered in Edmonton, Alberta, will file its related materials for this period. Miguel Martin, CEO, signed off on the report filed on June 4, 2025.

Why It Matters

This filing indicates Aurora Cannabis is preparing to release its financial performance for the fourth quarter and full fiscal year 2025, providing investors with key financial insights.

Risk Assessment

Risk Level: low — This is a routine announcement of an upcoming earnings call and filing, not a material event with immediate financial implications.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K filing serves as a report of foreign private issuer and includes a news release dated June 3, 2025, announcing Aurora Cannabis Inc.'s intention to host an investor conference call for its fourth quarter and fiscal year 2025 results.

When is Aurora Cannabis Inc. scheduled to host its investor conference call?

The news release included in the filing is dated June 3, 2025, indicating the announcement and likely the date around which the call will be scheduled.

Who signed the Form 6-K report?

The report was signed by Miguel Martin, Chief Executive Officer of Aurora Cannabis Inc.

What fiscal periods will the upcoming investor conference call cover?

The conference call will cover Aurora Cannabis Inc.'s fourth quarter and fiscal year 2025 results.

What is Aurora Cannabis Inc.'s principal executive office address?

Aurora Cannabis Inc.'s principal executive office is located at 2207 90B St. SW, Edmonton, Alberta, T6X 1V8, Canada.

From the Filing

0001279569-25-000577.txt : 20250604 0001279569-25-000577.hdr.sgml : 20250604 20250604103115 ACCESSION NUMBER: 0001279569-25-000577 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250603 FILED AS OF DATE: 20250604 DATE AS OF CHANGE: 20250604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 251022227 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News release dated June 3, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: June 3, 2025 EX-99.1 2 ex991.htm NEWS RELEASE DATED JUNE 3, 2025 Exhibit 99.1 Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information NASDAQ | TSX: ACB EDMONTON, AB, June 3, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday, June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, June 18, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events". About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on X and LinkedIn. Aurora

View on Read The Filing